{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:25:42Z","timestamp":1790889942077,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":5881,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1111\/j.1538-7836.2006.02226.x","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T10:33:23Z","timestamp":1161167603000},"page":"2411-2416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Peptidomimetic inhibitors for activated protein C: implications for hemophilia management"],"prefix":"10.1016","volume":"4","author":[{"given":"S.","family":"BUTENAS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"ORFEO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"KALAFATIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.G.","family":"MANN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0010","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","article-title":"Haemophilias A and B","volume":"361","author":"Bolton\u2010Maggs","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2005.01572.x","article-title":"Inherited defects of coagulation Factor V: the thrombotic side","volume":"4","author":"Vos","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0020","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood.V88.4.1183.bloodjournal8841183","article-title":"Moderation of hemophilia A phenotype by the factor V R506Q mutation","volume":"88","author":"Nichols","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1055\/s-0037-1613824","article-title":"Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A","volume":"83","author":"Lee","year":"2000","journal-title":"Thromb. Haemost"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2516.2001.00551.x","article-title":"Mild bleeding diathesis in a boy with combined severe haemophilia B (C(10400)>T) and heterozygous factor V Leiden","volume":"7","author":"Vianello","year":"2001","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0035","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1111\/j.1538-7836.2005.01639.x","article-title":"Factor V Leiden improves in vivo hemostasis in murine hemophilia models","volume":"3","author":"Schlachterman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0040","doi-asserted-by":"crossref","first-page":"20721","DOI":"10.1074\/jbc.272.33.20721","article-title":"Increased tissue factor\u2010initiated prothrombin activation as a result of the Arg506 >Gln mutation in factor VLEIDEN","volume":"272","author":"Van\u2018t Veer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.ATV.0000046238.23903.FC","article-title":"The dynamics of thrombin formation","volume":"23","author":"Mann","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0050","doi-asserted-by":"crossref","first-page":"23016","DOI":"10.1016\/S0021-9258(18)54456-2","article-title":"The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation","volume":"266","author":"Ye","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0055","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1021\/bi00645a029","article-title":"Anticoagulant properties of bovine plasma protein C following activation by thrombin","volume":"16","author":"Kisiel","year":"1977","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0060","doi-asserted-by":"crossref","first-page":"31869","DOI":"10.1016\/S0021-9258(18)31776-9","article-title":"The mechanism of inactivation of human factor V and human factor Va by activated protein C","volume":"269","author":"Kalafatis","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0065","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood.V59.5.1067.1067","article-title":"Mechanism of action of human activated protein C, a thrombin\u2010dependent anticoagulant enzyme","volume":"59","author":"Marlar","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0070","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bi00350a035","article-title":"Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity","volume":"25","author":"Eaton","year":"1986","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0075","doi-asserted-by":"crossref","first-page":"20139","DOI":"10.1016\/S0021-9258(18)54901-2","article-title":"Activated protein C\u2010catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity","volume":"266","author":"Fay","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0080","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1182\/blood.V91.12.4581","article-title":"Blood coagulation in hemophilia A and hemophilia C","volume":"91","author":"Cawthern","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0085","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V90.8.3067","article-title":"An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN)","volume":"90","author":"Van\u2018t Veer","year":"1997","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0090","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.V99.3.923","article-title":"Mechanism of factor VIIa\u2010dependent coagulation in hemophilia blood","volume":"99","author":"Butenas","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0095","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1002\/pro.5560060922","article-title":"The effect of Arg306\u2003>\u2003Ala and Arg506\u2003>\u2003Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S","volume":"6","author":"Egan","year":"1997","journal-title":"Protein Sci"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0100","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/oxfordjournals.jbchem.a134583","article-title":"Mechanism of inhibition of activated protein C by protein C inhibitor","volume":"95","author":"Suzuki","year":"1994","journal-title":"J Biochem (Tokyo)"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1042\/bj2950239","article-title":"Interaction of activated protein C with serpins","volume":"295","author":"Hermans","year":"1993","journal-title":"Biochem J"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0049-3848(02)00042-7","article-title":"Alpha 2\u2010macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C\/protein S system in cord and adult plasma","volume":"105","author":"Cvirn","year":"2002","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0115","doi-asserted-by":"crossref","first-page":"17606","DOI":"10.1016\/S0021-9258(19)47415-2","article-title":"Identification of divalent metal ion\u2010dependent inhibition of activated protein C by alpha 2\u2010macroglobulin and alpha 2\u2010antiplasmin in blood and comparisons to inhibition of factor Xa, thrombin, and plasmin","volume":"266","author":"Heeb","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0120","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1021\/bi992357p","article-title":"Tracking structural features leading to resistance of activated protein C to alpha 1\u2010antitrypsin","volume":"39","author":"Shen","year":"2002","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0125","doi-asserted-by":"crossref","first-page":"14864","DOI":"10.1021\/bi048833f","article-title":"Full or partial substitution of the reactive center loop of alpha\u20101\u2010proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition","volume":"43","author":"Filion","year":"2004","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0130","doi-asserted-by":"crossref","first-page":"15567","DOI":"10.1074\/jbc.C100123200","article-title":"Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor\u20101. Implications for the mechanism of profibrinolytic action of activated protein C","volume":"276","author":"Rezaie","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0135","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood.V91.5.1542","article-title":"Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin\u2010induced activation of protein C in human plasma","volume":"91","author":"Elisen","year":"1998","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0140","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1055\/s-0037-1616533","article-title":"Protein C inhibitor regulates the thrombin\u2013thrombomodulin complex in the up\u2010 and down regulation of TAFI activation","volume":"86","author":"Mosnier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0145","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbapap.2004.12.003","article-title":"Characterization of recombinant human protein C inhibitor expressed in Escherichia coli","volume":"1748","author":"Rehault","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0150","doi-asserted-by":"crossref","first-page":"25336","DOI":"10.1074\/jbc.270.43.25336","article-title":"Protein C inhibitor is a potent inhibitor of the thrombin\u2013thrombomodulin complex","volume":"270","author":"Rezaie","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0155","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.7164\/antibiotics.42.1506","article-title":"The inhibition of the enzymic activity of blood coagulation and fibrinolytic serine proteases by a new leupeptin\u2010like inhibitor, and its structural analogues, isolated from Streptomyces griseus","volume":"42","author":"Chi","year":"1989","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0160","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0049-3848(90)90268-H","article-title":"Inhibition of activated protein C by aprotinin and the use of the insolubilized inhibitor for its purification","volume":"59","author":"Taby","year":"1990","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0165","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0049-3848(93)90057-U","article-title":"Inhibition of activated protein C by benzamidine derivatives","volume":"69","author":"Sturzebecher","year":"1993","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0170","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1073\/pnas.90.17.8048","article-title":"Molecular basis for the inhibition of human alpha\u2010thrombin by the macrocyclic peptide cyclotheonamide A","volume":"90","author":"Maryanoff","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0175","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0049-3848(95)99612-C","article-title":"Direct inhibition of protein C by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy","volume":"78","author":"Callas","year":"1995","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0180","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.1016\/S0021-9258(18)32440-2","article-title":"The interaction of bovine factor V and factor V\u2010derived peptides with phospholipid vesicles","volume":"258","author":"Higgins","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0185","first-page":"397","article-title":"A simplified procedure for purification of human prothrombin, factor IX and factor X","volume":"11","author":"Bajaj","year":"1981","journal-title":"Prep Biochem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0190","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1074\/jbc.272.7.4367","article-title":"Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin\u2010III, and heparin cofactor\u2010II","volume":"272","author":"Van\u2018t Veer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1073\/pnas.78.1.162","article-title":"Isolation of functional human coagulation factor V by using a hybridoma antibody","volume":"78","author":"Katzmann","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0200","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/S0021-9258(18)89541-2","article-title":"Reactive site peptide structural similarity between heparin cofactor II and antithrombin III","volume":"260","author":"Griffith","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0205","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1021\/bi00138a023","article-title":"Aminonaphthalenesulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes","volume":"31","author":"Butenas","year":"1992","journal-title":"Biochemistry"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0210","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1016\/S0021-9258(19)86616-4","article-title":"The contribution of bovine factor V and factor Va to the activity of prothrombinase","volume":"254","author":"Nesheim","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0215","doi-asserted-by":"crossref","first-page":"23357","DOI":"10.1016\/S0021-9258(17)31661-7","article-title":"A model for the tissue factor pathway to thrombin. I. An empirical study","volume":"269","author":"Lawson","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1615\/CritRevEukarGeneExpr.v7.i3.40","article-title":"The regulation of clotting factors","volume":"7","author":"Kalafatis","year":"1997","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0225","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abio.1995.1148","article-title":"Fluorogenic substrates for activated protein C: substrate structure\u2013efficiency correlation","volume":"225","author":"Butenas","year":"1995","journal-title":"Anal Biochem"},{"key":"10.1111\/j.1538-7836.2006.02226.x_bb0230","doi-asserted-by":"crossref","first-page":"21527","DOI":"10.1074\/jbc.272.34.21527","article-title":"Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases","volume":"272","author":"Butenas","year":"1997","journal-title":"J Biol Chem"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2006.02226.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622116892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622116892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2006.02226.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:38:19Z","timestamp":1761532699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622116892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1538783622116892"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02226.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peptidomimetic inhibitors for activated protein C: implications for hemophilia management","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2006.02226.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}